Balchem Non-GAAP EPS of $1.57 beats by $0.04, revenue of $290.7M beats by $1.45M (NASDAQ:BCPC)
Balchem (BCPC) reported Q3 Non-GAAP EPS of $1.57, beating estimates by $0.04, with revenue of $290.7M, up 8.6% Y/Y and exceeding expectations by $1.45M. Adjusted EBITDA rose 12.4% Y/Y to $80.3M, and free cash flow was $57.9M. The stock gained 1.43% post-market.
How this was made
The 30-second read
Why it matters
The earnings beat supports a short‑term bullish bias, but the magnitude is modest.
Market read
Earnings beat provides a small catalyst for BCPC and may slightly lift the chemicals sector.
What to watch
Guidance for 2026 tax rate and a $650M credit facility could affect future cash flow.
Background
Balchem Corporation released its Q3 2026 earnings, reporting a non‑GAAP EPS beat and revenue beat.
Ticker impact
Q3 non‑GAAP EPS of $1.57 beat expectations by $0.04 and revenue of $290.7M beat by $1.45M.
likely modest upside as the market prices in the earnings beat
Both EPS and revenue exceeded consensus, and the stock already rose 1.43% pre‑market, indicating positive trader reaction.
Market effects
Positive earnings may lift the specialty chemicals sector.
U.S. market participants may view the beat as a sign of resilience in industrial chemicals.
Limited to U.S. investors; no broader macro impact.
Counterpoint
The beat is modest and may already be priced in; upside could be limited.
Key entities
- companyBalchem Corporation
U.S. specialty chemicals maker (NASDAQ:BCPC).